This study presents a profile of the patient who refuses chemotherapy. It is based on data from a group of 70 such cancer patients who were compared with a matched group of 70 cancer patients who completed their treatments at five oncological institutes in Israel. Despite the differences found on the Psychological Adjustment to Physical Illness Scale and the Brief Symptom Inventory scale, the model shows that the patient who refuses chemotherapy has low confidence in the physician and low expectation of the treatment.
Get full access to this article
View all access options for this article.
References
1.
BarofskyJ.SugarbakerP. H.MillsM. E.Compliance and quality of life assessment. In CohenS. J. (Ed.), New directions in patient compliance. Lexington, NY: Lexington Books, 1979. Pp. 59–73.
2.
BonadonaG.ValagussaP.Dose-response effect of adjuvant chemotherapy in breast cancer. The New England Journal of Medicine, 1981, 305, 948–949.
3.
BreslowN. E.DayN. E.HalvorsenK. T.PrenticeR. L.SabiL.Estimation of multiple palliative risk functions in matched case control studies. American Journal of Epidemiology, 1978, 108, 299–307.
4.
CarterS. K.Adjuvant chemotherapy of the breast. The New England Journal of Medicine, 1981, 304, 45–57.
DevitaV. J. R.SerpickA. A.CarboneP. P.Combination chemotherapy in the treatment of advanced Hodgkin's disease. Annals of Treatment Medicine, 1970, 79, 881–895.
8.
GlassA.VieandH. S.FisherB.RedmondC.LernerH.WalterJ.Acute toxicity during chemotherapy for breast cancer. The National Surgical Adjuvant Breast and Bowel Project (NSHBP). Cancer Treatment Report, 1981, 165, 363–376.
9.
GoldbergR. J.Systematic understanding of cancer patients who refuse treatment. Psychotherapy Psychosomatics, 1983, 39, 180–189.
10.
HarnellF.The PHGLM Procedure. In SAS supplemental library user's guide. Edilion Lory, NC: SAS Institute, Inc., 1980. Pp. 119–131.
11.
HollandJ. C.Coping with cancer: A challenge to behavioral science. In CullenJ. W.FoxB. H. (Eds.), Cancer: The behavioral dimensions. New York: Raven, 1976. Pp. 262–267.
12.
HollandJ. C.Advances in psychologic support. In BurchenalJ. H.AttgenH. F. (Eds.), Cancer: Achievement, challenges and prospects for the 1980s. Vol. 2. New York: Grune & Stratton, 1981. Pp. 723–733.
13.
LazloJ.LucasV. S.Emesis as critical problem in chemotherapy. The New England Journal of Medicine, 1981, 305, 948–949.
14.
LiberatiA.ColomboF.FranceschiS.AndreaniA.GonfalonierC.La VecchiaC.Quality of breast cancer care in Italian general hospitals. Lancet, 1982, 2, 31, 258–260.
15.
MeyerovitzB. E.Postmastectomy coping strategies and quality of life. Health Psychology, 1983, 2, 117–132.
16.
MilstedR.FoxM.TattersallM. H.WoodsR. C.Chemotherapy—what have we achieved. Lancet, 1980, 1, 1343–1346.
17.
NerenyD. R.LeventhalH.LoveR. R.Factors contributing to emotional distress during cancer chemotherapy. Cancer, 1982, 50, 1020–1027.
18.
PenmanD.DahnaG.HollandJ. C.Patients' perception of giving informed consent for investigational chemotherapy. Clinical Investigation, 1980, 108.
